No Data
No Data
No Data
No Data
No Data
Stereotaxis to Report First Quarter 2024 Financial Results on May 13, 2024
ST. LOUIS, April 22, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release financial
GlobeNewswireApr 22 19:51
Canopy Growth, Exact Sciences, Stereotaxis Among Healthcare Movers
Seeking AlphaApr 2 22:00
Lake Street Keeps Their Buy Rating on Stereotaxis (STXS)
TipRanksMar 25 20:45
Stereotaxis Set for Breakout Growth: Buy Rating Affirmed Amidst Regulatory Advances and Robust Financials
TipRanksMar 18 18:35
Stereotaxis Is Maintained at Buy by Lake Street
Stereotaxis Is Maintained at Buy by Lake Street
Dow JonesMar 6 01:22
Stereotaxis Price Target Raised to $4.00/Share From $3.00 by Lake Street
Stereotaxis Price Target Raised to $4.00/Share From $3.00 by Lake Street
Dow JonesMar 6 01:22
No Data
No Data